Gadolinium-based contrast agents (GBCA) are used for contrast-enhanced MRI and may significantly influence image interpretation and clinical decision. Indications for use of GBCAs to enhance the contrast-to-noise ratio in MRI are specific to each subspecialty. The session is organized by the Gadolinium Research and Education Committee of the ESMRMB to present the latest updates on the appropriate use of GBCA in common clinical contexts in neuroradiology and head and neck radiology.
Chairpersons' introduction
Common adult brain tumours
Inner ear and internal auditory canal imaging
Panel discussion: High-relaxivity GBCA and low/reduced GBCA dosing